MiniTEM™ event in Leiden attracts key players within gene therapy and vaccine industries

A full-day event including live demo of MiniTEM and presentations showing how to go from manual to automated virus particle characterization attracted more than 10 different companies located in Europe. Invited speaker Vesa Turkki, Senior Scientist at FinVector Vision Therapies gave a presentation explaining how MiniTEM helps them to link product understanding to process control during development of gene therapy products.